Stryker Corporation $SYK Stock: MBL Wealth LLC Decreases Position

MBL Wealth LLC lessened its holdings in shares of Stryker Corporation (NYSE:SYK) by 55.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,475 shares of the medical technology company’s stock after selling 1,830 shares during the period. MBL Wealth LLC’s holdings in Stryker were worth $406,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the business. Bank of America Corp DE acquired a new stake in Stryker in the second quarter valued at $1,404,284,000. Legal & General Group Plc purchased a new stake in shares of Stryker during the 2nd quarter worth $707,212,000. Jupiter Topco LLC acquired a new position in shares of Stryker during the 2nd quarter worth $681,581,000. Corient Private Wealth LP acquired a new position in shares of Stryker during the 2nd quarter worth $323,035,000. Finally, Flossbach Von Storch SE acquired a new position in shares of Stryker during the 2nd quarter worth $464,506,000. Hedge funds and other institutional investors own 77.09% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the stock. UBS Group initiated coverage on shares of Stryker in a report on Tuesday, July 28th. They issued a “buy” rating and a $400.00 price target for the company. Sanford C. Bernstein reissued a “market perform” rating on shares of Stryker in a report on Wednesday, October 7th. TD Cowen dropped their target price on shares of Stryker from $355.00 to $298.00 and set a “hold” rating for the company in a report on Tuesday, September 22nd. Raymond James Financial set a $370.00 price target on shares of Stryker in a research report on Friday, July 31st. Finally, BTIG Research reduced their price target on shares of Stryker from $358.00 to $316.00 and set a “buy” rating for the company in a research report on Monday, October 12th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $369.00.

Stryker Stock Up 0.2%

Stryker stock opened at $307.65 on Friday. Stryker Corporation has a fifty-two week low of $267.00 and a fifty-two week high of $389.33. The firm has a market capitalization of $118.01 billion, a price-to-earnings ratio of 31.88, a price-to-earnings-growth ratio of 1.98 and a beta of 0.78. The stock’s fifty day moving average is $295.23 and its two-hundred day moving average is $311.93. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.33 and a current ratio of 2.16.

Stryker (NYSE:SYK) last released its quarterly earnings results on Thursday, July 30th. The medical technology company reported $3.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.49 by $0.20. Stryker had a return on equity of 23.63% and a net margin of 14.43%. The business had revenue of $6.59 billion during the quarter, compared to the consensus estimate of $6.58 billion. During the same quarter in the previous year, the company posted $3.13 EPS. The business’s revenue was up 9.4% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. Analysts predict that Stryker Corporation will post 14.93 EPS for the current fiscal year.

Stryker Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be issued a dividend of $0.88 per share. This represents a $3.52 annualized dividend and a yield of 1.1%. The ex-dividend date is Wednesday, September 30th. Stryker’s dividend payout ratio (DPR) is 36.48%.

Insiders Place Their Bets

In other Stryker news, insider Debra King sold 826 shares of Stryker stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $336.30, for a total transaction of $277,783.80. Following the completion of the transaction, the insider owned 6,210 shares in the company, valued at approximately $2,088,423. The trade was a 11.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Dylan Crotty sold 441 shares of the company’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $328.61, for a total transaction of $144,917.01. Following the completion of the sale, the insider directly owned 6,102 shares in the company, valued at $2,005,178.22. This trade represents a 6.74% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 351,267 shares of company stock worth $118,197,701. Insiders own 4.60% of the company’s stock.

About Stryker

Stryker Corporation (NYSE: SYK) is a global medical technology company that develops and manufactures products used by healthcare providers in hospitals, surgical centers and other clinical settings. Its offerings are designed to support orthopaedic procedures, surgery, emergency care, neurovascular treatment and patient handling.

The company’s product portfolio includes orthopaedic implants and instruments, products for trauma and spine procedures, surgical equipment, endoscopy systems, patient beds and stretchers, emergency medical equipment, and neurovascular devices used in the treatment of conditions such as stroke.